(Q42129242)

17 October 2017

Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation (English)

1 reference

17 October 2017

0 references

1 reference

1 reference

0 references

D Balin-Gauthier

1

1 reference

17 October 2017

J-P Delord

2

1 reference

17 October 2017

M-J Pillaire

3

1 reference

17 October 2017

P Rochaix

4

1 reference

17 October 2017

J-S Hoffman

5

1 reference

17 October 2017

R Bugat

6

1 reference

17 October 2017

C Cazaux

7

1 reference

17 October 2017

P Canal

8

1 reference

17 October 2017

B C Allal

9

1 reference

17 October 2017

language of work or name

English

0 references

publication date

8 January 2008

1 reference

British Journal of Cancer

17 October 2017

1 reference

17 October 2017

98

1 reference

17 October 2017

1

1 reference

17 October 2017

120-128

1 reference

describes a project that uses

17 October 2017

ImageQuant

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC2359709/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Recognition and processing of cisplatin- and oxaliplatin-DNA adducts

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Molecular mechanisms of platinum resistance: still searching for the Achilles' heel

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Cellular and molecular pharmacology of oxaliplatin.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Alternative splicing of ERCC1 and cisplatin-DNA adduct repair in human tumor cell lines.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Glutathione S-transferases. The first enzymatic step in mercapturic acid formation

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Characterization of sequence-dependent synergy between ZD1839 ("Iressa") and oxaliplatin.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359709

Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas

17 August 2018

1 reference

12 December 2020

Anti-epidermal growth factor receptor monoclonal antibody 225 upregulates p27(KIP1) and p15(INK4B) and induces G1 arrest in oral squamous carcinoma cell lines

1 reference

12 December 2020

Epidermal growth factor

1 reference

12 December 2020

In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6604134

1 reference

17 October 2017

1 reference

17 October 2017

PubMed publication ID

18182978

1 reference